Stock BDPT BIOADAPTIVES, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Other languages BioAdaptives, Inc. Other OTC

Equities

BDPT

US09072U1079

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
Bioadaptives, Inc. Announces Naturacomplete?, an All-In-One Supplement to Optimize Its Ai-Based FYO Obesity Management System
BioAdaptives Announces Signing of a New Distributor?s Agreement for AI Body Composition Measuring App and New Weight Management System
BioAdaptives Inc. Announces the Development of PROTEINnMORETM
BioAdaptives Announces the Development of VeganHepPlusTM Liver Supplement Formula
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
BioAdaptives, Inc. Highlights Continued Success of Popular LUNG ARMOR System as US Enters Flu Season
BioAdaptives, Inc. Announces Nationwide Launch of Lung Fortress Natural Supplement
BioAdaptives, Inc. Commences Development of A New Supplement for Women?S Health
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
BioAdaptives, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
BioAdaptives, Inc. Announces the Appointment of David Allen to its Board of Directors
BioAdaptives, Inc. Signs Non-Exclusive Marketing Agreement with World Wellness, LLC
BioAdaptives, Inc. Announces the Appointment of Dr. Yaguang Liu to its Board of Directors
BioAdaptives, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
BioAdaptives, Inc. Auditor Raises 'Going Concern' Doubt
BioAdaptives Signs Non-Exclusive License with LY Research to Market Patented Product for Glucose Management
BioAdaptives, Inc. Establishes A Wholesale Division to Expand Marketing Presence in USD 151.9 Billion Global Dietary Supplement Market
BioAdaptives, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
BioAdaptives, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BDPT Stock
  4. BDPT Stock
  5. News BioAdaptives, Inc.
  6. Other languages